Adar Poonawalla

RCB ownership twist post-IPL win: Nikhil Kamath, Ranjan Pai, Adar Poonawalla in the fray, says report

Nov 07, 2025, 05:15 PM IST

Fresh off their historic IPL title win, Royal Challengers Bengaluru are suddenly facing a major off-field shake-up. The franchise’s parent company, Diageo, has decided to explore selling its stake, launching a formal review of its investment in the team.

RCB $2 bn sale to Adar Poonawalla: Will it trigger a rerating for CSK unlisted shares?

Oct 02, 2025, 02:35 PM IST

CSK share price: Unlisted shares of Chennai Super Kings might be set for a re-rating if the deal between Adar Poonawalla and Diageo is materialized for the proposed sale of RCB.

RCB stake sale to Adar Poonawalla: United Spirits shares clarification; shares react

Oct 01, 2025, 09:43 AM IST

Shares of United Spirits inched higher on Wednesday after it shared its clarification over media reports regarding stake sale of its cricket franchise Royal Challengers Bengaluru.

Adar Poonawalla plans $1 billion capital raise to expand NBFC operations

May 29, 2025, 02:05 PM IST

Adar Poonawalla-led Poonawalla Fincorp aims for primary infusion to support financial services growth

BTS - REINVENTING SERUM

May 29, 2025, 12:53 PM IST

Watch the latest episode of Business Today's Behind the Scenes(BTS), where we share an exclusive sneak-peek into the latest edition of the Business Today Reinventing Serum Magazine. In this episode, Sakshi Batra, Senior Associate Editor & Anchor at BTTV, has an insightful chat with Neetu Chandra, Senior Editor, Business Today and Rahul Oberoi, Chief of Research Bureau, Business Today. Watch the latest episode of Business Today's Behind the Scenes(BTS), where we share an exclusive sneak-peek into the latest edition of the Business Today Reinventing Serum Magazine. In this episode, Sakshi Batra, Senior Associate Editor & Anchor at BTTV, has an insightful chat with Neetu Chandra, Senior Editor, Business Today and Rahul Oberoi, Chief of Research Bureau, Business Today. In this episode, Neetu shares her insights on how Serum Institute of India has been quietly channeling its innovations across multiple domains, steadily expanding its impact beyond vaccines. Rahul offers his perspective on Reliance’s transformation across sectors and its efforts to streamline for a stronger market presence.

Will a fresh IMF loan provide temporary relief to Pakistan’s crumbling economy?

May 27, 2025, 05:40 PM IST

A fresh IMF loan might provide temporary relief to Pakistan's economy, in shambles for decades now, but will it be able to sustain without long-term reforms, especially after the military escalation with India reveals its priorities lie elsewhere?

India needs to back its innovators with capital: Adar Poonawalla

May 23, 2025, 08:17 PM IST

Adar Poonawalla, CEO, Serum Institute of India, on life after Covid, vaccine pricing, and expansion into new frontiers.

Growth Serum: Reinventing the world’s largest Covid vaccine supplier

May 23, 2025, 08:07 PM IST

In India, the most prominent symbol of the Covid response was the Serum Institute of India.

The new-look Serum: How Adar Poonawalla is looking to recapture the Covid windfall

May 23, 2025, 07:49 PM IST

Adar Poonawalla-led Serum Institute of India was the poster child of the fight against Covid-19 with Covishield. it is now undergoing a transformation by leveraging to shore up its finances, which fell off a cliff after the pandemic.

Exclusive | Adar Poonawalla On Vaccines, Real Estate, NBFCs And Bollywood

May 23, 2025, 01:30 PM IST

Serum Institute of India CEO Adar Poonawalla sat down with Siddharth Zarabi, Group Editor, Business Today, to share his vision for vaccine innovation, the future of India’s pharmaceutical industry, and his expanding business interests. He discusses the upcoming rollout of vaccines for dengue and chikungunya, shedding light on both the scientific promise and regulatory hurdles. Poonawalla called for policy reforms and a sustainable pricing framework that balances public health needs with private sector innovation. Venturing beyond healthcare, he reveals ambitious plans in real estate, financial services, and Bollywood—viewing India’s storytelling capabilities as a powerful global soft power tool. He also raises concern over the lack of risk capital for Indian entrepreneurs compared to international peers, urging for a more supportive investment climate. Poonawalla outlines Serum’s intent to remain privately held, even as he prepares a $1 billion capital raise to scale his NBFC business. Emphasizing policy stability and long-term vision, he underscores the role of entrepreneurship in positioning India as a global manufacturing and innovation powerhouse.

'Jio, LIC and now...': Insurance expert reacts to new players in general insurance sector

Mar 14, 2025, 10:30 AM IST

Patanjali Ayurved and DS Group, the maker of Rajnigandha, will purchase Magma General Insurance from Sanoti Properties LLP for a valuation of Rs 4,500 crore.